Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment.

MLA

Marbury, Thomas, et al. “Single-Dose Pharmacokinetic Studies of Abiraterone Acetate in Men with Hepatic or Renal Impairment.” Journal of Clinical Pharmacology, vol. 54, no. 7, July 2014, pp. 732–41. EBSCOhost, https://doi.org/10.1002/jcph.253.

APA

Marbury, T., Lawitz, E., Stonerock, R., Gonzalez, M., Jiao, J., Breeding, J., Haqq, C., Verboven, P., Stieltjes, H., Yu, M., Molina, A., Acharya, M., Chien, C., & Tran, N. (2014). Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment. Journal of Clinical Pharmacology, 54(7), 732–741. https://doi.org/10.1002/jcph.253

Chicago

Marbury, Thomas, Eric Lawitz, Robert Stonerock, Martha Gonzalez, James Jiao, Jim Breeding, Christopher Haqq, et al. 2014. “Single-Dose Pharmacokinetic Studies of Abiraterone Acetate in Men with Hepatic or Renal Impairment.” Journal of Clinical Pharmacology 54 (7): 732–41. doi:10.1002/jcph.253.